BridgeMD
New treatment option for Moyamoya Disease
Official title Remimazolam Consumption: TCI vs. Manual Infusion
ClinicalTrials.gov ID: NCT07377695
What this study is testing
- What it's testing
- The purpose of this prospective randomized controlled trial is to compare the total consumption of remimazolam between two different administration methods-Target-Controlled Infusion (TCI) and manual infusion-in patients undergoing cerebrovascular bypass surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Patients scheduled to undergo cerebrovascular bypass surgery under general anesthesia.
- American Society of Anesthesiologists (ASA) Physical Status 1, 2, or 3
- Adults aged 19 years or older
- Patients who have provided prior written informed consent to participate in the study
You likely can't join if
- Patients who do not consent to participate in the research
- Patients classified as ASA Physical Status 4
- Patients with a BMI ≤18.5 kg/m2 or 35.0 ≥ kg/m2
- History of allergy to benzodiazepine-class medications
- Patients with acute narrow-angle glaucoma
- Patients in a state of shock or coma
See the full eligibility criteria
- Patients scheduled to undergo cerebrovascular bypass surgery under general anesthesia.
- American Society of Anesthesiologists (ASA) Physical Status 1, 2, or 3
- Adults aged 19 years or older
- Patients who have provided prior written informed consent to participate in the study
- Patients who do not consent to participate in the research
- Patients classified as ASA Physical Status 4
- Patients with a BMI ≤18.5 kg/m2 or 35.0 ≥ kg/m2
- History of allergy to benzodiazepine-class medications
- Patients with acute narrow-angle glaucoma
- Patients in a state of shock or coma
- Acute alcohol intoxication with suppressed vital signs , or patients with alcohol or drug dependency
- Presence of Sleep Apnea Syndrome or severe/acute respiratory failure
- Patients with lactose intolerance or hypersensitivity to Dextran 40
The study team makes the final eligibility decision.
Where it's taking place
- Seongnam-si, Gyeonggi-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seongnam-si, Gyeonggi-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.